Free Trial

electroCore (ECOR) Competitors

electroCore logo
$5.09 -0.28 (-5.21%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$5.18 +0.09 (+1.87%)
As of 06/13/2025 05:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ECOR vs. LUCD, KRMD, PDEX, LUNG, ZJYL, OBIO, INFU, ICAD, MBOT, and GUTS

Should you be buying electroCore stock or one of its competitors? The main competitors of electroCore include Lucid Diagnostics (LUCD), KORU Medical Systems (KRMD), Pro-Dex (PDEX), Pulmonx (LUNG), Jin Medical International (ZJYL), Orchestra BioMed (OBIO), InfuSystem (INFU), iCAD (ICAD), Microbot Medical (MBOT), and Fractyl Health (GUTS). These companies are all part of the "medical equipment" industry.

electroCore vs. Its Competitors

electroCore (NASDAQ:ECOR) and Lucid Diagnostics (NASDAQ:LUCD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, community ranking, profitability and risk.

In the previous week, Lucid Diagnostics had 1 more articles in the media than electroCore. MarketBeat recorded 2 mentions for Lucid Diagnostics and 1 mentions for electroCore. electroCore's average media sentiment score of 1.87 beat Lucid Diagnostics' score of 0.96 indicating that electroCore is being referred to more favorably in the media.

Company Overall Sentiment
electroCore Very Positive
Lucid Diagnostics Positive

electroCore has a net margin of -54.40% compared to Lucid Diagnostics' net margin of -1,069.87%. Lucid Diagnostics' return on equity of 0.00% beat electroCore's return on equity.

Company Net Margins Return on Equity Return on Assets
electroCore-54.40% -154.45% -69.16%
Lucid Diagnostics -1,069.87%N/A -123.54%

electroCore has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Comparatively, Lucid Diagnostics has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500.

electroCore currently has a consensus price target of $25.50, suggesting a potential upside of 400.98%. Lucid Diagnostics has a consensus price target of $3.55, suggesting a potential upside of 175.19%. Given electroCore's higher possible upside, analysts plainly believe electroCore is more favorable than Lucid Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
electroCore
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Lucid Diagnostics
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20

electroCore received 124 more outperform votes than Lucid Diagnostics when rated by MarketBeat users. However, 68.25% of users gave Lucid Diagnostics an outperform vote while only 62.55% of users gave electroCore an outperform vote.

CompanyUnderperformOutperform
electroCoreOutperform Votes
167
62.55%
Underperform Votes
100
37.45%
Lucid DiagnosticsOutperform Votes
43
68.25%
Underperform Votes
20
31.75%

26.7% of electroCore shares are held by institutional investors. Comparatively, 74.0% of Lucid Diagnostics shares are held by institutional investors. 19.7% of electroCore shares are held by company insiders. Comparatively, 6.8% of Lucid Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

electroCore has higher revenue and earnings than Lucid Diagnostics. electroCore is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
electroCore$26.46M1.43-$18.83M-$1.56-3.26
Lucid Diagnostics$4.17M33.44-$52.67M-$1.34-0.96

Summary

Lucid Diagnostics beats electroCore on 11 of the 19 factors compared between the two stocks.

Get electroCore News Delivered to You Automatically

Sign up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ECOR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ECOR vs. The Competition

MetricelectroCoreElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$37.77M$3.33B$5.57B$8.50B
Dividend YieldN/A1.72%5.27%4.17%
P/E Ratio-2.7819.1726.7519.66
Price / Sales1.43195.99403.98152.07
Price / CashN/A44.0938.2534.64
Price / Book4.103.816.964.59
Net Income-$18.83M$94.03M$3.23B$248.23M
7 Day Performance-11.17%6.67%-1.22%-1.07%
1 Month Performance2.83%15.88%6.34%2.59%
1 Year Performance-17.37%31.17%33.05%13.50%

electroCore Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ECOR
electroCore
2.8127 of 5 stars
$5.09
-5.2%
$25.50
+401.0%
-17.4%$37.77M$26.46M-2.7850Negative News
LUCD
Lucid Diagnostics
3.2061 of 5 stars
$1.25
-10.4%
$3.50
+181.1%
+72.5%$134.70M$4.17M-1.0970Short Interest ↓
High Trading Volume
KRMD
KORU Medical Systems
3.3261 of 5 stars
$2.79
+3.3%
$4.50
+61.3%
+50.9%$128.73M$35.08M-11.1680Positive News
PDEX
Pro-Dex
3.2133 of 5 stars
$39.24
-2.0%
$56.00
+42.7%
+104.8%$127.96M$64.12M19.52140
LUNG
Pulmonx
3.6625 of 5 stars
$3.13
-7.9%
$11.59
+270.4%
-47.5%$126.01M$87.47M-2.17250News Coverage
ZJYL
Jin Medical International
N/A$0.80
+6.5%
N/A-74.2%$125.24M$23.50M0.00245Short Interest ↓
Gap Down
OBIO
Orchestra BioMed
3.0525 of 5 stars
$3.16
+10.9%
$14.20
+349.4%
-61.2%$121.07M$2.89M-1.964Positive News
INFU
InfuSystem
2.7496 of 5 stars
$5.68
-1.7%
$13.00
+128.9%
N/A$119.37M$137.58M94.68410News Coverage
Short Interest ↑
ICAD
iCAD
0.9762 of 5 stars
$3.88
+1.0%
N/A+142.1%$106.59M$19.53M-29.85140News Coverage
Positive News
Short Interest ↓
MBOT
Microbot Medical
1.9321 of 5 stars
$2.67
+5.1%
$9.00
+237.1%
+116.7%$97.13MN/A-3.3420News Coverage
Analyst Upgrade
Analyst Revision
Gap Down
GUTS
Fractyl Health
2.2996 of 5 stars
$1.90
flat
$11.00
+478.9%
-63.5%$93.06M$60K-0.16102News Coverage

Related Companies and Tools


This page (NASDAQ:ECOR) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners